Key to Success: A CDMO's Pathway to Biologics Excellence

What will this webinar address?

Biologics are growing in popularity due to their high efficacy and specificity but are complex and expensive to manufacture than traditional small-molecule drugs. In addition to facing rigorous regulations and a scarcity of skilled workforce, the pharmaceutical industry is grappling to adjust and cater to the pressing demands of the patient population.

To help overcome these challenges, CDMOs are playing their part in meeting industry demand by offering valuable contributions. From insights into technical challenges and implementing best practices, CDMOs help by reducing risk and expediting the path to market. Additionally, CDMOs excel in scaling up production efficiently and consistently, addressing the ongoing challenges that impede growth in the large molecule market. To ensure a successful journey from molecule to market, what considerations are needed when choosing the right partner

Join us, where our leading experts will provide first-class insight on how best to identify suitable CDMOs for your study.

Best practices in conducting successful due diligence on prospective CDMOs and key ‘asks’ to require from your CDMO partner

Assessing what innovations are being developed for biomanufacturing and analytical support and how this can mitigate biologic’s risks and reduce timing delays